Current Status

  • Preclinical evaluation of efficacy in rodent and large animal disease models
  • Academic partnerships with experts in cardiac, hepatic, and pulmonary fibrosis at Massachusetts General Hospital and at Duke University Medical Center
  • Preclinical ADMET studies to support IND filing

Next Steps

  • IND enabling studies
  • IND filing and first in human studies
  • Phase II proof of principal studies
  • Strategic opportunities